Resultados de la búsqueda 681-690 of 1386 for amitparikh.co.in

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  2. Hematología - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  3. Hematología - Ensayos clínicos

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.

  6. Cirugía torácica - Ensayos clínicos

    The Mayo Clinic Upper Digestive Disease Survey has been created in order to have a consistent evaluation tools for patients undergoing esophageal ...

  7. Procedimiento de Whipple - Médicos y departamentos - Mayo Clinic

    Mathur, Amit K. M.D.. Arizona. Miller, Laurence J. M.D.. Arizona. Pannala, Rahul M.D.. Arizona Minnesota. Wasif, Nabil M.D.. Arizona. Escrito por el personal de ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...